This site is intended for health professionals only
The American College of Chest Physicians has published new thrombosis guidelines with a weak recommendation for aspirin for primary prevention in patients over 50 years of age.
The recommendations are thought to be the first important guidelines published since research indicated a reduction in risk of cancer and mortality after aspirin use.
Vandvik said that the benefit to cardiovascular health and risk from bleeding “is pretty much well balanced”, but the suggestion of a reduced death risk may just push this in favour of aspirin.
He still emphasized that this guidance is not a general recommendation and doctors must discuss it with patients and portray it as something they may like to give thought.